Evolent Health, Inc

Evolent Health, Inc

4.38
EUR
0.00
(0.00%)
-3.99EPS
348.22MMarket Cap
Feb 24Next Earn
Evolent Health, Inc
GETTEX:9EH
(Gettex)

Recent

price

4.38

P/E

ratio

- -

div

yld

- -

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
USD
0.67
- -
3.86
5.64
6.76
8.11
8.34
10.89
10.55
14.43
17.65
22.28
16.43
20.87
Revenue per Share
0.52
-0.66
13.23
-3.55
-0.94
-0.68
-3.67
-3.94
-0.44
-0.2
-1.28
-0.81
-5.07
-4.52
Basic EPS, GAAP
-0.63
- -
-0.99
-1.13
-0.87
-0.78
-0.95
-0.54
-0.13
-0.94
1.02
-0.05
0.04
0.33
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
0.24
0.02
0.16
0.17
0.18
0.1
- -
Dividend per Share
- -
-0.05
15.65
13.36
13.53
14.45
10.9
7.34
7.77
8.6
9.38
8.7
3.72
3.3
Book Value per Share
-0.04
-0.05
-2.96
-3.48
1.89
0.51
0.49
0.07
-0.14
-3.06
-7.03
-7.1
-7.74
-7.61
Tangible Book Value per Share
38
38
25
45
64
77
82
85
86
94
111
115
114
112
Basic Weighted Avg Shares
26
- -
97
254
435
627
687
925
908
1,352
1,964
2,555
1,876
2,343
Sales/Revenue/Turnover
-82.41
- -
-44.36
-31.04
-16.65
-8.23
-17.85
-4.67
-3.21
-1.47
-1.07
-0.55
-1.06
-2
Operating Margin (%)
1
- -
7
17
32
45
61
61
60
67
123
118
116
110
Depreciation Expense
20
-25
332
-160
-61
-53
-302
-334
-38
-19
-113
-62
-535
-508
Net Income, GAAP
0.04
- -
6.84
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
78
- -
343.21
-62.84
-13.95
-8.4
-43.95
-36.15
-4.14
-1.42
-5.76
-2.41
-28.49
-21.67
Profit Margin (%)
51
- -
125
133
245
219
36
144
78
45
9
-108
121
127
Working Capital
- -
- -
- -
120
121
221
363
326
273
469
635
515
974
972
LT Debt
31
-2
935
912
1,046
1,189
929
620
694
859
1,068
1,001
415
373
Total Equity
- -
- -
-8.59
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
74.03
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
-23.63
-7.08
-4.89
-29.23
-43.35
-5.73
-2.47
-14.76
-9.03
-81.81
-83.57
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
9
2
1
LT Borrowings
973
966
969
LT Finance Leases
3
2
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
112
113
113
Market Capitalization
259
605
395

Working Capital

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
502
611
617
Cash, Cash Equivalents & STI
142
116
148
Accounts Receivable, Net
314
449
443
Inventories
- -
- -
- -
Total Current Liabilities
381
493
490
Payables & Accruals
108
83
77
ST Debt
9
2
1
Deferred Revenue
1
1
1

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-3.39%
-0.93%
-58.53%
Free Cash Flow
20.93%
19.89%
-177.59%
Net Income, GAAP
133.49%
214.8%
767.39%
Sales/Revenue/Turnover
41.77%
19.18%
-26.56%
Total Cash Common Dividend
- -
196.29%
187.45%

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
640
647
621
647
2,555
2025
484
444
480
469
1,876
2026
496
653
725
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.22
-0.06
-0.27
-0.27
-0.81
2025
-0.63
-0.44
-0.24
-3.84
-5.07
2026
-0.24
-0.25
-0.21
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.04
0.04
0.04
0.04
0.18
2025
0.04
0.04
0.02
- -
0.1
2026
- -
- -
- -
- -
- -
Business
Evolent Health, Inc. (NYSE: EVH) provides specialty care management services to health plans and providers in oncology, cardiology, musculoskeletal, and primary care markets across the United States. The company offers an integrated technology platform including Identifi for data aggregation, analytics, care workflows, and patient engagement; clinical program management encompassing clinical pathways and decision support; care management services; risk adjustment; pharmacy benefits management; population health management; value-based care enablement; revenue cycle management; and advance care planning through Vital Decisions. Founded in 2011 and headquartered in Arlington, Virginia, Evolent partners with leading payers and providers to align care with clinical evidence, member preferences, and seamless delivery across settings. In September 2025, Evolent agreed to sell its accountable care organization business, Evolent Care Partners, to Privia Health for $100 million in cash plus up to $13 million contingent on 2025 Medicare Shared Savings Program performance, enabling debt reduction and a strategic focus on core specialty care management. The company announced more than $500 million in newly contracted annualized revenue set to launch in 2026 during its third quarter 2025 earnings release in November 2025, reflecting strong growth momentum. Evolent reported fiscal 2024 revenue of approximately $1.96 billion, up 17.8% year-over-year, with continued expansion in value-based care solutions.

Company News

  • Financial Review: Evolent Health (EVH) and Its Competitors

  • Evolent Health, Inc. (EVH) Q3 2026 Earnings Call Transcript

  • What Evolent Health (EVH) Said on Its Q3 Earnings Call

  • Evolent Health (EVH) Matches Q3 Earnings Estimates

  • Compared to Estimates, Evolent Health (EVH) Q3 Earnings: A Look at Key Metrics

  • Evolent Announces Third Quarter 2026 Results

  • Analyzing CareCloud (NASDAQ:CCLD) & Evolent Health (NYSE:EVH)

  • Evolent To Release Third Quarter 2026 Financial Results on Thursday, November 5, 2026

  • Evolent Health, Inc (NYSE:EVH) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

  • TransPerfect Selected by Evolent for Enterprise-Wide Telephonic Interpretation

  • Evolent Health Q2 Earnings Review: Debt Is Distressing, But Business Is Booming

  • Dimensional Fund Advisors LP Has $4.08 Million Stock Position in Evolent Health, Inc $EVH

  • Evolent Health Q2 Earnings Call Highlights

  • Evolent Health, Inc. (EVH) Q2 2026 Earnings Call Transcript

  • Compared to Estimates, Evolent Health (EVH) Q2 Earnings: A Look at Key Metrics

  • Evolent Health (EVH) Tops Q2 Earnings and Revenue Estimates

  • Evolent Announces Second Quarter 2026 Results

  • Forget Nvidia. These 5 S&P 500 stocks are quietly going all in on AI.

  • Healthcare IT is the Next AI Growth Story: 3 Stocks to Buy Now

  • Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026